HRT FINANCIAL LP

Position in IRWD — Ironwood Pharmaceuticals Inc

CIK 1475597 NEW YORK, NY

Position in IRWD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,430,588

+$2,378,393 QoQ

Shares Held

577,337

+1349.0% QoQ

Ownership

0.349%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#35

of 212 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $132,018,496 across 28 Drug Manufacturers - Specialty & Generic names. IRWD ranks #11 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	98,864	$53,567,481
2	ZTS	Zoetis Inc.	241,369	$17,344,776
3	BCRX	Biocryst Pharmaceuticals Inc	1,081,523	$10,815,230
4	TEVA	Teva Pharmaceutical Industries Ltd	295,918	$10,025,701
5	AMPH	Amphastar Pharmaceuticals, Inc.	387,530	$7,820,355
6	HLN	Haleon plc	682,281	$6,365,681
7	ANIP	Ani Pharmaceuticals Inc	63,008	$5,215,802
8	TAK	Takeda Pharmaceutical Co Ltd	278,706	$4,467,657

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,430,588	577,337	+1349.0%	Shares	Defined	2026-08-14
2025-09-30	$52,195	39,844	-33.9%	Shares	Defined	2025-11-14
2024-06-30	$392,966	60,271	-68.2%	Shares	Defined	2024-08-12
2023-12-31	$2,165,317	189,276	-21.8%	Shares	Defined	2024-02-09
2023-09-30	$2,330,816	242,037	+21.2%	Shares	Defined	2023-11-13
2023-06-30	$2,125,286	199,745	+44.6%	Shares	Defined	2023-08-11
2023-03-31	$1,453,516	138,167	-57.1%	Shares	Defined	2023-05-12
2022-12-31	$3,987,461	321,829	-52.5%	Shares	Defined	2023-02-10
2022-09-30	$7,016,133	677,233	+1175.9%	Shares	Defined	2022-11-14
2021-09-30	$693,185	53,077	-33.0%	Shares	Defined	2021-11-15
2021-06-30	$1,019,098	79,184	+424.9%	Shares	Defined	2021-08-16
2020-12-31	$171,829	15,086	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.